Indirubin-3'-monoxime-5-sulphonic acid is primarily utilized in biomedical research due to its potential therapeutic properties. It is studied for its role in inhibiting specific enzymes, such as cyclin-dependent kinases (CDKs), which are involved in cell cycle regulation. This makes it a candidate for investigating treatments for diseases characterized by abnormal cell proliferation, such as cancer. Additionally, it is explored for its anti-inflammatory and neuroprotective effects, offering potential applications in managing inflammatory disorders and neurodegenerative conditions. Its sulfonic acid group enhances solubility, making it more suitable for experimental and pharmacological studies.